IFN-γ licenses CD11b+ cells to induce progression of systemic lupus erythematosus
Namir Shaabani1,2, Nadine Honke1,2, Sebastian Dolff3, Boris Görg2, Vishal Khairnar1, Katja Merches1, Vikas Duhan1, Sabine Metzger4, Mike Recher5, Carmen Barthuber6, Cornelia Hardt1, Peter Proksch7, Dieter Häussinger2, Oliver Witzke3, Philipp A. Lang2,8, Karl S. Lang1,2
1Institute of Immunology, Medical Faculty, University Duisburg-Essen, Essen, Germany
2Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
3Department for Nephrology, Medical Faculty, University Duisburg-Essen, Essen, Germany
4Metabolomics Facility, Cologne Biocenter, University Cologne, Cologne, Germany
5Clinic for Primary Immunodeficiency, Medical Outpatient Unit and Immunodeficiency Lab, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
6Department of Laboratory Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
7Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
8Department of Molecular Medicine II, Heinrich-Heine-University Düssledorf, Düsseldorf, Germany
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Autoimmunity
Tập 62
11-21
Thông tin tác giả